Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-026181

CEO and Chairman sold 15,000 shares at an average $41.81 ($627,107)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2021-04-06 Sale −1,600 $41.08 $65,728 1,761,861 D
ROBINS CHAD M CEO and Chairman 2021-04-06 Sale −2,200 $42.48 $93,456 1,759,661 D
ROBINS CHAD M CEO and Chairman 2021-04-06 Sale −1,200 $43.08 $51,696 1,758,461 D
ROBINS CHAD M CEO and Chairman 2021-04-07 Sale −3,900 $40.61 $158,379 1,754,561 D
ROBINS CHAD M CEO and Chairman 2021-04-07 Sale −1,100 $41.45 $45,595 1,753,461 D
ROBINS CHAD M CEO and Chairman 2021-04-08 Sale −2,943 $42.04 $123,724 1,750,518 D
ROBINS CHAD M CEO and Chairman 2021-04-08 Sale −1,957 $43.00 $84,151 1,748,561 D
ROBINS CHAD M CEO and Chairman 2021-04-08 Sale −100 $43.78 $4,378 1,748,461 D
Open-market sales · 15,000 sh · avg $41.81 · $627,107
Loading xslF345X03/doc4.xml…